Kathy Connell 
Kathy is Director of New Ventures, Australia and New Zealand (ANZ) for Johnson & Johnson Innovation, Asia-Pacific and is responsible for implementing our strategy across Australia and New Zealand.
Kathy has a clinical background and started her commercial career as the VP of Global Business Development for an Australian biotechnology company. Prior to joining Janssen, Kathy worked for Sanofi engaged in in-licensing late stage pharmaceutical assets. Kathy joined Janssen as Biotechnology Alliance Manager in 2011.
Kathy is a registered psychologist and holds Post Graduate Diplomas in Health and Medical Law from the University of Melbourne, Psychology from Monash University and Bachelor degrees in Psychology (Swinburne University) and Applied Science from LaTrobe University. She is based in Sydney Australia.